Live Breaking News & Updates on Obseva Announcesrelationshipwith Syneos Health

ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix -Linzagolix, an oral GnRH antagonist, is pending regulatory approval in the U.S. and Europe for the treatment ....

United States , Shauna Dillon , Brian Ocallaghan , Joyce Allaire , Michelle Keefe , Canaccord Genuity , Exchange Commission On , Obseva Announcesrelationshipwith Syneos Health To Commercialize Linzagolix , Solutions At Syneos Health , Syneos Health Nasdaq , Swiss Exchange , Exchange Commission , Management Inc , Syneos Health , Oxford Finance , Obseva Announcesrelationshipwith Syneos Health , Commercial Solutions , Supply Agreement , North American , Nasdaq Global Select Market , Note Regarding Forward Looking Statements , Private Securities Litigation Reform Act , Risk Factors , Annual Report ,